Pharma-Bio CMOs Continue With Robust Construction Activity, an Industrial Info Market Brief

Both large and small Pharmaceutical & Biotech companies continue to rely on contract manufacturing organizations (CMOs) to scale up and expand their drug product manufacturing. Many smaller life-science concerns also rely on CMOs to handle all of the manufacturing of their novel products, so as not to be burdened with the cost of constructing and operating a manufacturing facility. Major contract manufacturers include Catalent, Patheon, Pfizer, Lonza, AbbVie, Royal DSM and Baxter. Pfizer is an example of a major pharmaceutical company that offers contract manufactured items as well as its own proprietary products.

Industrial Information is tracking 235 major CMO capital projects in North America, with a total investment value of $5.8 billion.